Hand-held ultrasound manufacturer SonoSite is ramping up its Asian presence. The Bothell, WA-based firm has established a subsidiary in Hong Kong and a branch office in Shanghai to provide direct sales and support for its products to the People’s
Hand-held ultrasound manufacturer SonoSite is ramping up its Asian presence. The Bothell, WA-based firm has established a subsidiary in Hong Kong and a branch office in Shanghai to provide direct sales and support for its products to the Peoples Republic of China. Introduced to the Chinese market at the SinoMed meeting in Beijing in May, the companys SonoSite 180 system will be available there in the fourth quarter.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.